Inventor · disambiguated record
Gisela Backfisch
Also filed as: BACKFISCH GISELA
15 granted patents·12 pending applications·63 citations·filing 2000–2024
89Inventor score
Top patents by PatentIndex Score
27 records- 0190US8076326B2N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted Dec 13, 2011·23 cites·28 claims
- 0283US8183237B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted May 22, 2012·4 cites·17 claims
- 0383US7144902B1Prodrugs of thrombin inhibitorsABBOTT GMBH & CO KG·Filed 2000·Granted Dec 5, 2006·23 cites·4 claims
- 0480US8343959B2N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2011·Granted Jan 1, 2013·5 cites·10 claims
- 0576US7851463B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Dec 14, 2010·2 cites·21 claims
- 0673US9573950B2Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulatorsABBVIE DEUTSCHLAND·Filed 2015·Granted Feb 21, 2017·2 cites·48 claims
- 0772US8362010B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2010·Granted Jan 29, 2013·2 cites·23 claims
- 0871US2025296917A1Spiro-cyclic amine derivatives as s1p modulatorsABBVIE DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 0966US8598211B2Carboxamide compounds and their use as calpain inhibitors IVKLING ANDREAS·Filed 2010·Granted Dec 3, 2013·1 cites·13 claims
- 1065US8101754B2Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorUNGER LILIANE·Filed 2005·Granted Jan 24, 2012·1 cites·21 claims
- 1162US2022169620A1Spiro-cyclic amine derivatives as s1p modulatorsABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 1251US2014179702A1Carboxamide compounds and their use as calpain inhibitors ivABBVIE INC·Filed 2013·Application pending·0 cites
- 1349US2017158693A1Hexahydrodiazepinoquinolines carrying a cyclic radicalABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 1449US2020002354A1Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disordersABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 1548US2013018047A1N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptorABBOTT LAB·Filed 2012·Application pending·0 cites
- 1648US2017112851A1Hexahydrodiazepinoquinolines carrying a substituted alkyl radicalABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 1745US9051304B2Carboxamide compounds and their use as calpain inhibitors VKLING ANDREAS·Filed 2010·Granted Jun 9, 2015·0 cites·11 claims
- 1844US9540376B2Hexahydrodiazepinoquinolines carrying a substituted alkyl radicalABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 10, 2017·0 cites·36 claims
- 1944US8470810B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2010·Granted Jun 25, 2013·0 cites·20 claims
- 2042US9150545B2Carboxamide compounds and their use as calpain inhibitors VABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 6, 2015·0 cites·22 claims
- 2141US9150553B2Carboxamide compounds and their use as calpain inhibitorsHORNBERGER WILFRIED·Filed 2008·Granted Oct 6, 2015·0 cites·11 claims
- 2241US2015252017A1Carboxamide compounds and their use as calpain inhibitors vABBVIE DEUTSCHLAND·Filed 2015·Application pending·0 cites
- 2341US2018339996A1Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disordersABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 2440US2020039930A1Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radicalABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2540US2012095015A1Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorUNGER LILIANE·Filed 2011·Application pending·0 cites
- 2638US9062027B2Carboxamide compounds and their use as calpain inhibitors VKLING ANDREAS·Filed 2011·Granted Jun 23, 2015·0 cites·7 claims
- 2735US2019062305A1Pyridyl or pyrazinyl compounds carrying a methyl-bound alpha-amino acid amide groupABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gisela Backfisch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →